209 related articles for article (PubMed ID: 11986015)
1. Long-term survival after esophagectomy for Barrett's adenocarcinoma in endoscopically surveyed and nonsurveyed patients.
Ferguson MK; Durkin A
J Gastrointest Surg; 2002; 6(1):29-35; discussion 36. PubMed ID: 11986015
[TBL] [Abstract][Full Text] [Related]
2. Surveillance in Barrett's esophagus: an audit of practice.
Ajumobi A; Bahjri K; Jackson C; Griffin R
Dig Dis Sci; 2010 Jun; 55(6):1615-21. PubMed ID: 19669878
[TBL] [Abstract][Full Text] [Related]
3. [Impact of endoscopic surveillance of Barrett's esophagus on survival of patients with esophageal adenocarcinoma].
Incarbone R; Bonavina L; Bassi F; Peracchia A
Chir Ital; 2002; 54(5):591-6. PubMed ID: 12469454
[TBL] [Abstract][Full Text] [Related]
4. Barrett's esophagus with high-grade dysplasia. An indication for prophylactic esophagectomy.
Heitmiller RF; Redmond M; Hamilton SR
Ann Surg; 1996 Jul; 224(1):66-71. PubMed ID: 8678620
[TBL] [Abstract][Full Text] [Related]
5. Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients.
Peters JH; Clark GW; Ireland AP; Chandrasoma P; Smyrk TC; DeMeester TR
J Thorac Cardiovasc Surg; 1994 Nov; 108(5):813-21; discussion 821-2. PubMed ID: 7967662
[TBL] [Abstract][Full Text] [Related]
6. Barrett's esophagus: a retrospective analysis of 13 years surveillance.
Switzer-Taylor V; Schlup M; Lübcke R; Livingstone V; Schultz M
J Gastroenterol Hepatol; 2008 Sep; 23(9):1362-7. PubMed ID: 18205769
[TBL] [Abstract][Full Text] [Related]
7. Surgical management of Barrett's esophagus.
Clark GW; DeMeester TR
Ann Chir Gynaecol; 1995; 84(2):139-44. PubMed ID: 7574371
[TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma.
Larghi A; Lightdale CJ; Ross AS; Fedi P; Hart J; Rotterdam H; Noffsinger A; Memeo L; Bhagat G; Waxman I
Endoscopy; 2007 Dec; 39(12):1086-91. PubMed ID: 17701854
[TBL] [Abstract][Full Text] [Related]
9. EUS followed by EMR for staging of high-grade dysplasia and early cancer in Barrett's esophagus.
Larghi A; Lightdale CJ; Memeo L; Bhagat G; Okpara N; Rotterdam H
Gastrointest Endosc; 2005 Jul; 62(1):16-23. PubMed ID: 15990814
[TBL] [Abstract][Full Text] [Related]
10. Preventing death of Barrett's cancer: does frequent surveillance endoscopy do it?
Sontag SJ
Am J Med; 2001 Dec; 111 Suppl 8A():137S-141S. PubMed ID: 11749939
[TBL] [Abstract][Full Text] [Related]
11. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.
Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I
Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526
[TBL] [Abstract][Full Text] [Related]
12. The management of high grade dysplasia and early cancer in Barrett's esophagus. A multidisciplinary problem.
Rusch VW; Levine DS; Haggitt R; Reid BJ
Cancer; 1994 Aug; 74(4):1225-9. PubMed ID: 8055442
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcome of esophagectomy for high-grade dysplasia or cancer found during surveillance for Barrett's esophagus.
Chang LC; Oelschlager BK; Quiroga E; Parra JD; Mulligan M; Wood DE; Pellegrini CA
J Gastrointest Surg; 2006 Mar; 10(3):341-6. PubMed ID: 16504878
[TBL] [Abstract][Full Text] [Related]
14. Surgical treatment of Barrett's carcinoma. Correlations between morphologic findings and prognosis.
Lerut T; Coosemans W; Van Raemdonck D; Dillemans B; De Leyn P; Marnette JM; Geboes K
J Thorac Cardiovasc Surg; 1994 Apr; 107(4):1059-65; discussion 1065-6. PubMed ID: 8159027
[TBL] [Abstract][Full Text] [Related]
15. Extent of resection and lymphadenectomy in early Barrett's cancer.
Korst RJ; Altorki NK
Dis Esophagus; 1997 Jul; 10(3):172-8. PubMed ID: 9280075
[TBL] [Abstract][Full Text] [Related]
16. Risk of malignant progression in Barrett's esophagus indefinite for dysplasia.
Ma M; Shroff S; Feldman M; DeMarshall M; Price C; Tierney A; Falk GW
Dis Esophagus; 2017 Mar; 30(3):1-5. PubMed ID: 28184470
[TBL] [Abstract][Full Text] [Related]
17. Does Barrett's esophagus respond to chemoradiation therapy for adenocarcinoma of the esophagus?
Barthel JS; Kucera ST; Lin JL; Hoffe SE; Strosberg JR; Ahmed I; Dilling TJ; Stevens CW
Gastrointest Endosc; 2010 Feb; 71(2):235-40. PubMed ID: 20003971
[TBL] [Abstract][Full Text] [Related]
18. Endoscopic Treatment of Early Barrett's Adenocarcinoma and Dysplasia: Focus on Submucosal Cancer.
Frei N; Frei R; Semadeni GM; Jochum W; Brand S; Borovicka J
Digestion; 2019; 99(4):293-300. PubMed ID: 30176662
[TBL] [Abstract][Full Text] [Related]
19. The rationale for esophagectomy as the optimal therapy for Barrett's esophagus with high-grade dysplasia.
Edwards MJ; Gable DR; Lentsch AB; Richardson JD
Ann Surg; 1996 May; 223(5):585-9; discussion 589-91. PubMed ID: 8651749
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal outcomes of radiofrequency ablation versus surveillance endoscopy for Barrett's esophagus with low-grade dysplasia.
Kahn A; Al-Qaisi M; Kommineni VT; Callaway JK; Boroff ES; Burdick GE; Lam-Himlin DM; Temkit M; Vela MF; Ramirez FC
Dis Esophagus; 2018 Apr; 31(4):. PubMed ID: 29036431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
